Prevention and treatment of kidney transplantation rejection by means of innovative therapeutic apheresis. - ND
- Conditions
- Patients waiting for first corpse kidney transplantation or re-transplantation, with PRA values > 50%MedDRA version: 9.1Level: LLTClassification code 10023439Term: Kidney transplant rejection
- Registration Number
- EUCTR2008-007047-13-IT
- Lead Sponsor
- OSPEDALE POLICLINICO S. MATTEO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Patients of 18-70 years old; Patients in emodialysis suitable for kidney transplantation; patients with PRA > 50%; absence of active infections and procalcitonine in the normality ranges; absence of neoplastic processes; absence of active heart diseases; signed informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Absence of one of the inclusion criteria.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method